This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
We are thrilled to offer the first CRI Virtual Immunotherapy Patient Summit. Register for free today.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy from Drs. Elizabeth M. Jaffee, Marijo Bilusic, Ranee Mehra, and Suzanne L. Topalian.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy with Drs. Adi Diab, Jianjun Gao, Andrew Sikora, and Valentina Hoyos Velez.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy with Drs. Vamsidhar Velcheti, Sylvia Adams, Claire Friedman, and Gulam A. Manji.
Register for a free, virtual event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy with Drs. David Reardon, Suzanne Baumeister, Justin Gainor, and Kimmie Ng.
Register for a free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy from Drs. Tanya Dorff, Roger Lo, Aaron Miller, and Rebecca Shatsky.
Patients, caregivers, and advocates learn about new breakthroughs in cancer immunotherapy from Drs. Andrew Sikora, Renata Ferrarotto, Cassian Yee, Jun Zhang, and Adi Diab.
Patients, caregivers, and advocates learn about new breakthroughs in cancer immunotherapy from Drs. Ezra Cohen, Aaron Miller, Sandip Patel, and Rebecca Shatsky.
Patients, caregivers, and advocates learn online about new breakthroughs in cancer immunotherapy from Drs. Charles Drake, Jedd Wolchok, Catherine M. Diefenbach, and Gulam A. Manji.
CRI.ContactUs
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.